Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongfei Duan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
BMC Infectious Diseases|January 5, 2021
Use of T-SPOT.TB for the diagnosis of unconventional pleural tuberculosis is superior to ADA in high prevalence areas: a prospective analysis of 601 casesXinting Yang, Jing Zhang, Qingtao Liang, et al.
The Journal of Infection|April 1, 2023
Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlasYi Wang, Qing Sun, Yun Zhang, et al.
The Journal of Clinical Investigation|September 2, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitisXiao-Jing Zhang, Jiajun Fu, Xu Cheng, et al.
Gates Open Research|March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y Chen, Laura E Via, Lori E Dodd, et al.
Science Translational Medicine|January 7, 2026
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesionsStephanus T Malherbe, Ray Y Chen, Xiang Yu, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
PET/CT guided tuberculosis treatment shortening: a randomized trialStephanus T Malherbe, Ray Y Chen, Xiang Yu, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
BMC Infectious Diseases|January 5, 2021
Use of T-SPOT.TB for the diagnosis of unconventional pleural tuberculosis is superior to ADA in high prevalence areas: a prospective analysis of 601 casesXinting Yang, Jing Zhang, Qingtao Liang, et al.
The Journal of Infection|April 1, 2023
Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlasYi Wang, Qing Sun, Yun Zhang, et al.
The Journal of Clinical Investigation|September 2, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitisXiao-Jing Zhang, Jiajun Fu, Xu Cheng, et al.
Gates Open Research|March 13, 2018
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y Chen, Laura E Via, Lori E Dodd, et al.
Science Translational Medicine|January 7, 2026
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesionsStephanus T Malherbe, Ray Y Chen, Xiang Yu, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
PET/CT guided tuberculosis treatment shortening: a randomized trialStephanus T Malherbe, Ray Y Chen, Xiang Yu, et al.
Pageof 4